Company Filing History:
Years Active: 2017
Title: Ilka Knippertz – Innovator in Immunology
Introduction
Ilka Knippertz, an accomplished inventor based in Nürnberg, Germany, has made significant contributions to the field of immunology. With a focus on dendritic cell-specific therapies, her innovative work is paving the way for advanced treatment options in managing diseases related to malignancy, autoimmunity, and transplant rejections.
Latest Patents
Knippertz holds a patent for the "Mutant CD83 promoter and use thereof." This groundbreaking invention features a mutant CD83 promoter that encompasses the promoter/enhancer regions of the human CD83 promoter. The unique application of this promoter has promising implications for therapeutic strategies targeting various medical conditions related to the immune response.
Career Highlights
Ilka Knippertz is currently affiliated with Friedrich-Alexander-Universität Erlangen-Nürnberg, where she conducts her research. Her dedication to advancing medical science is reflected in her innovative work and the impact of her inventions in the biomedical field.
Collaborations
Throughout her career, Knippertz has collaborated with esteemed colleagues, including Alexander Steinkasserer and Marcello Stein. These partnerships have further enriched her research and helped in the development of new methodologies and applications in immunology.
Conclusion
As a leading inventor in her field, Ilka Knippertz exemplifies the spirit of innovation and research. Her patent for the mutant CD83 promoter demonstrates her commitment to improving health outcomes through scientific discovery and collaboration.